Skip to content
Recall Observatory FDA recall evidence

Drug product

Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.

D-0516-2023

March 23, 2023

Class II

Product summary

Firm
Preferred Pharmaceuticals, Inc.
Event
Event 91952
Status
Ongoing
Classification
Class II
Quantity
a) 135 Bottles, b) 24 Bottles
Official record key
drug-enforcement:D-0516-2023

Official wording

Reason: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Code information: a) Lot: A1321V, D0221J, Exp. Date:8/31/2023; Lot: A1322J, Exp. Date: 5/31/2024; Lot: F0221Q, I0121E, I1021R, J1122D, Exp. Date: 10/31/2023; b) Lot: B0422J, Exp. Date: 5/31/2024; Lot: C1721K, Exp. Date: 8/31/2023; Lot: K1022Q, Exp. Date:11/30/2024.

Distribution pattern: USA Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP Deviations